Nisa Investment Advisors LLC Boosts Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Nisa Investment Advisors LLC boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 7.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,977 shares of the company’s stock after buying an additional 5,091 shares during the quarter. Nisa Investment Advisors LLC’s holdings in HCA Healthcare were worth $29,660,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently made changes to their positions in HCA. Bangor Savings Bank lifted its stake in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares during the last quarter. MFA Wealth Advisors LLC purchased a new stake in HCA Healthcare during the 2nd quarter valued at about $27,000. Unique Wealth Strategies LLC purchased a new position in HCA Healthcare in the 2nd quarter worth approximately $28,000. GPS Wealth Strategies Group LLC boosted its stake in shares of HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. bought a new stake in HCA Healthcare during the 2nd quarter valued at $33,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Trading Down 1.9 %

Shares of NYSE HCA opened at $356.63 on Tuesday. HCA Healthcare, Inc. has a 52-week low of $222.23 and a 52-week high of $417.14. The company has a market cap of $93.41 billion, a PE ratio of 17.78, a P/E/G ratio of 1.52 and a beta of 1.67. The firm’s 50 day moving average price is $394.71 and its 200-day moving average price is $352.94. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s payout ratio is currently 13.16%.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the sale, the senior vice president now owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of analyst reports. UBS Group boosted their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Barclays increased their price objective on HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Truist Financial upped their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Finally, KeyCorp reduced their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research report on Monday. Five investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and three have given a strong buy rating to the company’s stock. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $379.11.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.